Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ingredients by Nature Earns Patent for Use of Eriocitrin in Blood Glucose Formulations - Nutraceuticals World
Market Updates, Products & Ingredients, Regulations

Ingredients by Nature Earns Patent for Use of Eriocitrin in Blood Glucose Formulations

Patent claim relates to reducing blood glucose levels at a dose of 100-200 mg eriocitrin per day.

Ingredients by Nature (IBN), supplier of citrus-derived flavonoids and ingredients, has gained approval from the USPTO on a patent for the use of eriocitrin in ingredient formulations, such as Eriomin.
 
The eriocitrin patent claim is stated as “A method of reducing blood glucose levels in a human subject in need thereof, comprising administering to the subject a composition comprising 100-200 mg eriocitrin once per day.” It will be officially issued in two to three months and published with its accompanying patent number.
 
“We couldn’t be happier with the progress we have made to recognize eriocitrin as a viable option for better health,” said Rob Brewster, president of IBN. “Supported by a successful first clinical trial and now this patent, our line of Eriomin lemon flavonoid blends, which are primarily comprised of eriocitrin, provide powerful support to managing healthy blood glucose levels. We look forward to revealing additional significant results from ongoing research into the effect that eriocitrin can have on blood glucose levels later this year.”
 
Two versions of Eriomin are currently available, Eriomin Glucose for prediabetes management and Eriomin Esport for a healthy gaming lifestyle, which help maintain blood glucose levels within the normal range, according to the company.
 

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters